Skip to main content
Neil Dunavin, MD, Hematology, San Francisco, CA, UCSF Medical Center

NeilCurtisDunavinMD

Hematology San Francisco, CA

Physician

Dr. Dunavin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Dunavin's full profile

Already have an account?

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2013 - 2016
  • Ohio State University Hospital
    Ohio State University HospitalResidency, Internal Medicine, 2009 - 2012
  • University of Kansas School of Medicine
    University of Kansas School of MedicineClass of 2009

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2019 - 2025
  • MD State Medical License
    MD State Medical License 2015 - 2022
  • KS State Medical License
    KS State Medical License 2016 - 2020
  • OH State Medical License
    OH State Medical License 2009 - 2017
  • DC State Medical License
    DC State Medical License 2013 - 2014
  • American Board of Internal Medicine Hematology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • LAG3 Inhibition Decreases AML-Induced Immunosuppression and Improves T Cell-Mediated Killing
    Neil Dunavin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Press Mentions

  • Emerging Agents, Treatment Selection Criteria Key to Improving Outcomes in Myelofibrosis
    Emerging Agents, Treatment Selection Criteria Key to Improving Outcomes in MyelofibrosisJanuary 20th, 2020
  • Dr. Dunavin on Treatment Considerations in Myelofibrosis
    Dr. Dunavin on Treatment Considerations in MyelofibrosisJanuary 10th, 2020

Hospital Affiliations